Relay Therapeutics OverviewRelay Therapeutics Other Income Expense Net
Other Income/Expense Net for RLAY.
Quarterly Other Income/Expense
$5.30M
↓ 32.1% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$23.75M
↓ 47.17% YoY
Trailing 12 months ending Mar 31, 2026